CI

At a glance

ClinicalIndex Comparison Record
Phase 2Recruiting· 144 target
Drug / intervention
Baitouweng Tang +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06421818
NCT06421818Phase 2RecruitingOn TrackUpdated 25mo ago

Formula-to-Syndrome Effect and Pharmacomicrobiomics Mechanism of Colon Delivery of Baitouweng Decoction for Treating Large Intestine Damp-heat Syndrome of Ulcerative Colitis

The Second Hospital of Nanjing Medical University·interventional·Posted May 20, 2024·Updated May 21, 2024

In Brief

A Phase 2 clinical trial evaluating Baitouweng Tang and Placebo for Ulcerative Colitis. Currently recruiting, targeting 144 participants across 1 site.

Detailed Summary

Baitouweng Decoction is traditionally used to treat large intestine damp-heat syndrome of ulcerative colitis (UC) by oral administration and rectal enema.The project applicant's invention of transendoscopic entral tubing (TET) has been used in Baitouweng Decoction for the treatment of UC across the whole colon, however, the efficacy have not been reported and the underlying mechanism is still unclear. Compared with oral and rectal enema, Baitouweng Decoction by colon TET can improve the therapeutic effect by increasing the concentration of drugs in the whole colon, which need to be verified. This project will reveal the prescription effect and drug-microbiome interaction mechanism of whole colon repeated administration of Baitouweng Decoction in the treatment of UC through clinical randomized controlled studies, deep intestinal dynamic sampling, integrated analysis of multi-omics and TCM prescription metabolomics studies, and provide key scientific basis for the establishment of a new approach of whole colon repeated administration of TCM and a new strategy for the treatment of UC.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChina

Timeline

Phase 2Recruiting
202520262027
First PostedMay 20, 2024
Enrollment StartMay 1, 2024
Primary CompletionDec 30, 2026
TodayJul 1, 2026
Enrollment to primary: 2.7 yearsPosted 2.1 years agoPrimary completion in 6 months

Interventions

Baitouweng Tangdrug

Baitouweng Decoction is composed of four herbs: Baitouweng, Rhizoma coptidis, Phellodendri huangbai and Qin Pi.

Placeboother

The same volume and color as Baitouweng Decoction.